Cargando…
Activity and perspective on quantitative modeling and simulation in Japan: Update from the Pharmaceuticals and Medical Devices Agency
Autores principales: | Kijima, Shinichi, Yoshida, Shuya, Ochiai, Yoshinori |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755913/ https://www.ncbi.nlm.nih.gov/pubmed/36199197 http://dx.doi.org/10.1002/psp4.12868 |
Ejemplares similares
-
Meeting Report: PMDA Public Workshop on Pharmacometrics at Japan
por: Kijima, Shinichi, et al.
Publicado: (2020) -
Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory Perspective
por: Sato, M, et al.
Publicado: (2017) -
Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan
por: Handa, Nobuhiro, et al.
Publicado: (2019) -
Reporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan()
por: Handa, Nobuhiro, et al.
Publicado: (2015) -
A regulatory perspective on recombinant collagen-based medical devices
por: Liu, Wenbo, et al.
Publicado: (2021)